The potential of chitosan for the oral administration of peptides.
about
Biocompatibility of chitosan carriers with application in drug delivery.Nanotechnology approaches for inhalation treatment of fibrosis.A new strategy based on SmRho protein loaded chitosan nanoparticles as a candidate oral vaccine against schistosomiasisRecent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents.A poly(ethylene glycol)-based surfactant for formulation of drug-loaded mucus penetrating particles.Biodistribution and endocytosis of ICAM-1-targeting antibodies versus nanocarriers in the gastrointestinal tract in mice.Transport of nanocarriers across gastrointestinal epithelial cells by a new transcellular route induced by targeting ICAM-1.The performance of nanocarriers for transmucosal drug delivery.Dense chitosan surgical membranes produced by a coincident compression-dehydration process.Design aspects of poly(alkylcyanoacrylate) nanoparticles for drug delivery.Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues.Formulation strategies to improve oral peptide delivery.Biocompatibility and Stability of Polysaccharide Polyelectrolyte Complexes Aimed at Respiratory Delivery.Control of size dispersity of chitosan biopolymer microparticles and nanoparticles to influence vaccine trafficking and cell uptake.Physicochemical properties of mucus and their impact on transmucosal drug delivery.Oral delivery of glucagon like peptide-1 by a recombinant Lactococcus lactis.Toxicity evaluation of inorganic nanoparticles: considerations and challenges
P2860
Q33649839-47C92794-A5BE-46B4-80F3-58D5CC63A998Q34449624-999ED0EA-D9BA-47CC-BBF3-69CE4D367F66Q34500826-02DCACF5-FE9E-4FB6-A40B-8C4FE308379AQ34733812-D0AB36A9-F89E-42A0-B1DC-B4646336FB66Q35634184-1E4C9EA4-B047-47E6-94C2-07274365354AQ36161142-4EF2333C-FF62-48BB-86F9-BD2EEC8E26B6Q36291228-F558E75D-FD6C-424D-B9B7-C8EB4BF1D7E3Q36527739-67B665BF-80A1-48C7-ACE7-965C93509470Q36756873-C9F0008D-0B4C-4093-A688-0B9E81F94306Q37015849-5CD1464A-A937-4445-8C34-6DD8BF31A7FCQ37153923-5E9142C4-3DD3-4D0A-B248-BE1C8EA6AF2EQ38226675-7D839DA6-6248-438A-88AC-3CBA2F67778BQ41029569-67F3D8B5-ACB7-421E-820C-7A2D0BEFE103Q47316700-9641A5FE-C2A7-485C-A5A3-A02882AA20F4Q47791593-10F152EB-178D-472C-A2CB-CDDAA0AF7770Q51748194-2AC23223-5571-41C2-B3BE-F773E37D9BF9Q57765661-017C0B85-94B7-421F-AFFB-F1B4061893A9
P2860
The potential of chitosan for the oral administration of peptides.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
The potential of chitosan for the oral administration of peptides.
@ast
The potential of chitosan for the oral administration of peptides.
@en
type
label
The potential of chitosan for the oral administration of peptides.
@ast
The potential of chitosan for the oral administration of peptides.
@en
prefLabel
The potential of chitosan for the oral administration of peptides.
@ast
The potential of chitosan for the oral administration of peptides.
@en
P2860
P356
P1476
The potential of chitosan for the oral administration of peptides
@en
P2093
Cecilia Prego
Dolores Torres
P2860
P304
P356
10.1517/17425247.2.5.843
P407
P577
2005-09-01T00:00:00Z